| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK-J4 hydrochloride |
|---|
| Description | Cell-permeable. An ethyl ester derivative of the JMJD3 selective histone demethylase inhibitor GSK-J1 (Cat. No. 2260-1, 5) (IC50> 50 μM in vitro. When administered to human primary macrophages, GSK-J4 can reduce lipopolysaccharide (LPS)-induced proinflammatory cytokine production, most notably including that of TNFα (IC50 = 9 μM). MW: 454. Purity ≥95% |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Ethyl 3-?((6-?(4,?5-?dihydro-?1H-?benzo[d]azepin-?3(2H)-?yl)-?2-?-(pyridin-2- yl)pyrimidin-4-yl)amino)propanoate, monohydrochloride |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 2259-5 |
|---|
| Price | |
|---|
| Order / More Info | GSK-J4 hydrochloride from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|